ArticleOncoTargets and therapy2021
Erratum: Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.